Employees: 3,611
Size Shenzhen Sunnypol Optoelectornics (002876.SZ) is a China Health Care company (Medical Specialties) with a market value of $680M, the 2953rd largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥27.05 on 18 Nov 2026.
Performance Over six months the shares fell 8.9%, against -15.1% for the median peer and -20.0% for the China market (cap-weighted) — 8th highest of 21 in its peer set.
Growth Revenue grew 29.4% over the last twelve months (peer median +15.8%); the operating margin is 4.6% (peer median 17.0%).
Valuation It trades at 39.0× forward earnings against a peer median of 20.7× (4th most expensive of 17).
Price implies For today's price to make sense, revenue must grow about 10% a year for seven years (Req g). Recent delivered growth is +14%, so the hurdle is -4 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 2.3 points below its cost of capital (8.7% WACC).
Next results Next results expected around 12 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥4.35B | CN¥3.68B | CN¥2.58B | CN¥2.06B | CN¥2.17B |
| Revenue growth | — | +43% | +25% | -5% | — |
| Gross profit | CN¥922M | CN¥540M | CN¥418M | CN¥283M | CN¥450M |
| EBITDA | n/a | CN¥376M | CN¥261M | CN¥165M | CN¥344M |
| Net income | CN¥122M | CN¥47.1M | CN¥68.1M | CN¥42.8M | CN¥206M |
| Free cash flow | CN¥346M | -CN¥157M | -CN¥438M | -CN¥630M | CN¥164M |
| Capital expenditure | CN¥144M | CN¥350M | CN¥481M | CN¥679M | CN¥252M |
| Total debt | CN¥2.58B | CN¥2.59B | CN¥1.82B | CN¥1.24B | CN¥965M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 002876.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -5.7% | -6.6% | 11th highest of 21 |
| 6-month return | -8.9% | -15.1% | 8th highest of 21 |
| Distance from 52-week high | -23.9% | -35.5% | 8th highest of 21 |
| Revenue growth (TTM) | +29.4% | +15.8% | 9th highest of 21 |
| Operating margin | 4.6% | 17.0% | 7th lowest of 21 |
| Forward P/E | 39.0× | 20.7× | 4th most expensive of 17 |
| Growth the price implies (Req g, 7 yrs) | 10.1% | -0.6% | 7th most demanding of 17 |
| Growth delivered (Del g) | +14.2% | +14.5% | 9th highest of 17 |
| Hurdle (Req g minus delivered) | -4.0 pp | -14.7 pp | 5th most demanding of 17 |
| ROIC minus cost of capital | -2.3 pp | +5.1 pp | 6th lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Shenzhen Sunnypol Optoelectornics 002876.SZ | China | $680M | -9% | +29% | 5% | 39.0× | 10.1% | +14.2% |
| Delcath Systems DCTH | United States | $685M | +75% | +38% | 5% | 358.9× | 33.4% | +120.2% |
| Livsmed 491000.KS | South Korea | $687M | -47% | +89% | -77% | n/a | n/a | n/a |
| Shenzhen Lifotronic Technology 688389.SS | China | $692M | -14% | +14% | 13% | 29.9× | 11.6% | +13.3% |
| Shanghai Sanyou Medical 688085.SS | China | $692M | -23% | +15% | 4% | 50.0× | 29.0% | +6.8% |
| Anhui Hongyu Wuzhou Medical Manufacturer 301234.SZ | China | $697M | +148% | -14% | 3% | n/a | 31.8% | -0.6% |
| Shanghai Kinetic Medical 300326.SZ | China | $662M | -10% | -28% | 17% | 26.0× | 6.6% | -1.9% |
| Synektik SNT.WA | Poland | $662M | +10% | +32% | 24% | 13.8× | 0.2% | +47.5% |
| Shanghai INT Medical Instruments 1501.HK | Hong Kong | $700M | -25% | +35% | 21% | 15.9× | -3.3% | +23.5% |
| Japan Lifeline 7575.T | Japan | $703M | +34% | +6% | 19% | 14.5× | -9.5% | +2.9% |
| QuidelOrtho QDEL | United States | $657M | -20% | -5% | -2% | 10.7× | n/a | n/a |
| SWS Hemodialysis Care 688410.SS | China | $706M | -11% | +31% | 19% | 23.5× | 16.2% | +25.9% |
| Doctorglasses Chain 300622.SZ | China | $710M | -22% | +6% | 14% | 22.8× | -3.4% | +15.7% |
| AK Medical 1789.HK | Hong Kong | $642M | -23% | +16% | 26% | 10.5× | -11.5% | +6.7% |
| Caina Technology 301122.SZ | China | $721M | +36% | +61% | 0% | 55.4× | n/a | n/a |
| Beijing Chunlizhengda Medical Instruments 1858.HK | Hong Kong | $631M | -28% | -9% | 31% | 8.5× | -9.5% | +1.5% |
| SunMax Biotechnology 4728.TWO | Taiwan | $630M | 0% | +19% | 51% | n/a | -2.6% | +18.8% |
| Shanghai Aladdin Biochemical Technology 688179.SS | China | $736M | -37% | +39% | 24% | 27.4× | 17.1% | +24.2% |
| BMC Medical 301367.SZ | China | $737M | -17% | +37% | 17% | 18.7× | -1.5% | +15.6% |
| Beijing Aerospace Changfeng 600855.SS | China | $738M | -44% | -10% | -19% | n/a | n/a | n/a |
| InMode INMD | United States | $741M | -8% | +2% | 18% | 9.8× | -10.8% | +12.4% |